Middle East & Africa Allergy Diagnostics And Therapeutics Market Size & Outlook
Middle East & Africa allergy diagnostics and therapeutics market, 2018-2030 (US$M)
Related Markets
MEA allergy diagnostics and therapeutics market highlights
- The MEA allergy diagnostics and therapeutics market generated a revenue of USD 1,548.8 million in 2023.
- The market is expected to grow at a CAGR of 6.3% from 2024 to 2030.
- In terms of segment, inhaled was the largest revenue generating allergen type in 2023.
- Other Allergens is the most lucrative allergen type segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 1,548.8 million |
| Market revenue in 2030 | USD 2,369.5 million |
| Growth rate | 6.3% (CAGR from 2023 to 2030) |
| Largest segment | Inhaled |
| Fastest growing segment | Other Allergens |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Inhaled, Drug, Other Allergens, Food |
| Key market players worldwide | Rohm Co Ltd, Thermo Fisher Scientific Inc, PerkinElmer, BioMerieux SA, Siemens Healthineers AG ADR, Omega Healthcare Investors Inc, Danaher Corp, Alcon Inc, AbbVie Inc, Sanofi SA, Allergy Therapeutics PLC, Pfizer Inc, Teva Pharmaceutical Industries Ltd, GSK PLC, Sun Pharmaceutical Industries, Roche Holding AG, Merck & Co Inc, Astellas Pharma Inc, Epigenomics AG |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.9% of the global allergy diagnostics and therapeutics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 9,489.1 million by 2030.
Inhaled was the largest segment with a revenue share of 55.07% in 2023. Horizon Databook has segmented the Middle East & Africa allergy diagnostics and therapeutics market based on inhaled, drug, other allergens, food covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East and Africa hold major growth opportunities, as majority of the market is untapped due to the unavailability of organized screening programs in this region, especially in underdeveloped African economies. In the past few years, countries such as the UAE, Morocco, & South Africa have implemented regulations for organizing the healthcare and pharmaceutical sector.
Collaborations of various companies and government institutes to supply important drugs and tests related to allergies are also expected to boost the market. These initiatives are anticipated to lead to the development of novel therapeutics and diagnostics.
However, a shortage of experienced professionals, a lack of awareness about treatment related to allergies, and lack of political support & necessary resources may restrain the market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy Diagnostics And Therapeutics Market Scope
Allergy Diagnostics And Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
MEA allergy diagnostics and therapeutics market size, by country, 2018-2030 (US$M)
Middle East & Africa Allergy Diagnostics And Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
